|
The Cochrane Collaboration
Cochrane Reviews |
| Explore | New + Updated | Other languages |
|
|
|
Topical glyceryl trinitrate for rotator cuff diseaseCumpston M, Johnston RV, Wengier L, Buchbinder R SummaryGlyceryl trinitrate patches for rotator cuff diseaseThis summary of a Cochrane review presents what we know from research about the effect of glyceryl trinitrate patches on rotator cuff disease (RCD). Pain - glyceryl trinitrate patches (5 mg/day) may improve pain slightly. Symptoms of RCD - it is uncertain whether glyceryl trinitrate patches (5 mg/day) eliminate symptoms of RCD because of the very low quality of the evidence.
Physical Function
Side Effects - it is uncertain whether topical glyceryl trinitrate (5 mg/day) has side effects such as headache because of the very low quality of the evidence. What is rotator cuff disease and what is glyceryl trinitrate? The rotator cuff is a group of tendons that surrounds the shoulder joint. In some people, the muscles and tendons pinch when they move their shoulder over and over again. The pinching can cause the rotator cuff to swell, break down and it may tear away from the bone - this is called rotator cuff disease or tendonitis. In a lot of people, it is a normal part of ageing and they may not have symptoms. But many people with rotator cuff disease do have pain in their shoulder at some time that may not go away on its own. Topical glyceryl trinitrate (also called nitroglycerin or nitroglycerine) has been used to treat chest pain for many years, and has been proposed as a promising treatment for muscle and tendon injuries. For treatment of soft tissue conditions glyceryl trinitrate is delivered topically, through the skin, using medicated patches.
This is a Cochrane review abstract and plain language summary, prepared and maintained by The Cochrane Collaboration, currently published in The Cochrane Database of Systematic Reviews 2010 Issue 1, Copyright © 2010 The Cochrane Collaboration. Published by John Wiley and Sons, Ltd.. The full text of the review is available in The Cochrane Library (ISSN 1464-780X).
This version first published online:
July 08. 2009 AbstractBackgroundRotator cuff disease is a common cause of shoulder pain. Topical glyceryl trinitrate is a possible new treatment. ObjectivesTo determine the effectiveness and safety of topical glyceryl trinitrate for rotator cuff disease. Search strategyWe searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, SPORTDiscus, PEDro, the Australian Clinical Trials Registry, Current Controlled Trials (to October 2007) and the references and citations of included studies. Selection criteriaWe included randomised controlled trials and controlled clinical trials of people with rotator cuff disease who received topical glyceryl trinitrate, alone or in combination, compared to placebo or active therapy. Data collection and analysisTwo authors independently assessed risk of bias and extracted data. Main resultsThree small studies, one at moderate risk of bias and two at high risk of bias, were included. Meta-analysis was precluded due to different interventions and outcome measures. Study participants also had differing durations of symptoms and data for pain and function could only be extracted from one study. One placebo-controlled trial (20 participants) tested 5 mg glyceryl trinitrate patches, used daily for three days, among participants with 'acute supraspinatus tendinitis' of less than seven days duration. Treatment resulted in reduced pain intensity (adjusted MD -3.50, 95% CI -3.96 to -3.04). Function was not measured. One trial (53 participants) compared one quarter of a 5 mg glyceryl trinitrate patch used daily for up to 24 weeks combined with rehabilitation to placebo patches and rehabilitation among participants with 'supraspinatus tendinopathy' for longer than six months. A third trial (48 participants) tested 5 mg glyceryl trinitrate patches, used daily for three days, compared to corticosteroid injection among participants with 'rotator cuff tendinitis' of less than six-weeks duration. Fifteen out of 24 participants in the glyceryl trinitrate treatment reported headache (RR 0.11, 95% CI 0.01 to 1.96). Authors' conclusionsThere is some evidence from one study at high risk of bias that topical glyceryl trinitrate is more effective than placebo for rotator cuff disease among patients with acute symptoms (< seven-days duration), but there is insufficient evidence to be certain about their longer-term effects. Headache was a common side effect in one trial and any benefits of treatment need to be balanced against the risk of headache. Further high quality research is needed to determine the effectiveness and safety of this new therapy. |